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CpG methylationA precise biologicalmechanism bywhich cadmiumacts as a developmental toxicant is unknownbut is suggested
to include an epigenetic basis. In prior work, we analyzed CpG island methylation levels within gene promoters
(n= 16,421) in leukocytes collected frommothers and their infants from a pregnancy cohort in DurhamCounty,
North Carolina. The CpGmethylation levelswere examined in relationship to prenatal exposure to cadmiumand/
or cotinine to identify genes and pathways inﬂuenced by in utero exposure. In the present article, we provide an
enhanced description of the data collection and processing to facilitate cross-study comparisons. Data are
available within the Gene Expression Omnibus database (GSE67976).
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Brief overview
1. DNA methylation assessment
1.1. Sample selection
To facilitate reproducibility and to disseminatemethods to as large an
audience as possible, this article provides additional details on the study
design and analysismethods. Thematerials andmethods presented here
represent an expansion of those detailed in the original study [1].
Study samples were collected from within the Children's Environ-
mental Health Initiative's (CEHI) Healthy Pregnancy, Healthy Baby
study in Durham County, North Carolina [1] (Fig. 1, Step 1). The CEHI
study population includes 1854 mother–infant pairs and is a prospec-
tive cohort study of pregnant women living in Durham County, North
Carolina recruited between the years of 2005 and 2011. The study was
approved by institutional review boards at both Duke University and
the University of North Carolina-Chapel Hill. All subjects consented to
have maternal venous blood and their newborn's cord blood drawn at
delivery for use for toxicant assessment and genetic analysis. Population
eligibility requirements included: planned delivery at Duke University
Medical Center, at least 18 years of age, English literacy, residence in
Durham County, and no presence of multi-fetal gestation or knownntal Sciences and Engineering,
Carolina, Chapel Hill, NC, USA.
. This is an open access article underfetal genetic or congenital anomalies. A detailed description of post-
blood-collection processing, including the analysis of cadmium (Cd)
and cotinine levels, is reported in Edwards et al. [2].
From the total CEHI study population of 1854mother–infant pairs, a
total of 17 maternal–fetal pairs were selected for the DNA methylation
analysis (Fig. 1, Step 2). The rationale for sample selectionwas to stratify
the pairs by higher or lower Cd exposure for comparison. A median Cd
blood level of 0.40 μg/l and a 75th percentile level of 0.56 μg/l were
reported in the larger CEHI cohort [2]. The limits of detection for Cd
reported in the study were 0.20 μg/l and 0.08 μg/l Cd depending on
the laboratory of analysis. The corresponding cotinine detection limit
was either 0.02 or 2.0 ng/l, depending on the laboratory of analysis.
Inter-laboratory differenceswere accounted for using a rankpermutation
method [1,3]. The Cd and cotinine levels of themother–infant pairs select-
ed for DNA methylation assessment are reported in the prior study [1].1.2. Assessment of CpG methylation
After selection of the mother–infant pair samples, corresponding
blood samples were retrieved for processing. DNA was extracted using
Qiagen's PAXgene Blood DNA kits (Fig. 1, Step 3). The recovered DNA
was stored in nuclease free water at −80 °C between processing
steps. The MethylCollector Ultra Kit from Active Motif was used to
isolate only CpG methylated DNA ﬁrst cut via enzymatic digestion.
This kit takes advantage of the methylated-CpG island recovery assaythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Flowchart depicting methodology for sample collection and data processing from Sanders et al. [1].
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plex for double-stranded CpG-methylated DNA to pull down only CpG
methylated fragments [4]. These fragments were then ampliﬁed using
theWGA3 kit (Sigma), to produce copies of the DNA sequences. Finally,
the ampliﬁed DNAwas hybridized to Affymetrix Human Promoter 1.0R
arrays used to assess over 4.6 million sites (probes), with each probe
comprising a 25 bp region within gene promoters (Fig. 1, Step 4).
These steps were followed for all DNA samples (maternal and fetal)
using the manufacturer's protocols.
The 4.6 million probe dataset per sample were then processed
bioinformatically to yield summarized CpG island methylation abun-
dances for 16,421 genes. Summarized CpG island data were generated
by averaging all probe methylation abundances located within the
CpG islands based upon location in the genome. CpG island locations
were determined as detailed by the UCSC database [5] (Fig. 1, Step
5) and annotated according to the Human Genome 18.
1.3. Identiﬁcation of differentially methylated genes
The methylation datasets (n = 34 datasets, 16,421 CpG islands/
dataset) recovered from the previous step were then classiﬁed into a
Cd-exposed or unexposed group (Fig. 1, Step 6). The Cd-exposed
group was deﬁned as N0.20 μg/l (median) maternal blood Cd. CotinineTable 1
General Study Information.
Subject area Epigenetics, DNA methylation
Cell type Leukocyte
Population description 17 Mother–Infant Pairs
Total number of samples 34
Technologies utilized
DNA extraction Qiagen PAXgene Blood DNA kit
Methylated DNA collection kit Active Motif MethylCollector Ultra kit
DNA ampliﬁcation kit Sigma WGA3 kit
Microarray type Affymetrix Human Promoter 1.0R Arrays
Pathway analysis Ingenuity pathway analysis software and Database
for Annotation, Visualization, and Integrated
Discovery (DAVID)
Measurement Variable DNA methylation levels at promoter-based
CpG Islands
Link to Public Data http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE67976is a known indicator of nicotine exposure and was also analyzed in
this study to examine the epigenetic effects of smoking. For the cotinine
analysis, cotinine exposure or unexposed groups were deﬁned as those
with any detectable value versus no detectable level. The rationale for
this choice was to assess all forms of smoking exposure, including
second-hand smoke.
CpG island methylation was then compared within the binary com-
parison groups using an ANOVA. The criteria for differentialmethylation
between CpG islands were as follows: (1) minimum absolute change of
30%DNAmethylation between the exposed andunexposed groups; and
(2) p b 0.05. Table 1 presents general study information. The results of
the ANOVA analyses are summarized in Table 2.
2. Quality control and confounder adjustment
2.1. Controlling for confounding demographic variables
The effect of covariates on differential DNAmethylation was assessed
in both maternal and newborn DNA based on the known association
of maternal age, race, and infant sex with DNA methylation patterns.
Covariates were dichotomized where maternal age was deﬁned as ≥30
versus b30 (referent), maternal race was deﬁned as non-Hispanic Black
versus non-Hispanic White (referent) and one Hispanic mother was ex-
cluded from these analyses due to insufﬁcient sample size and infant
sex (male= referent) (Fig. 1, Step 8A). CpG islandmethylationwas com-
paredwithin the binary comparison groups using an ANOVAwith criteria
identical to those above. Differentially methylated CpG islands were
identiﬁed for each demographic (maternal age, race, or infant sex)
and excluded from the sets of identiﬁed Cd- and cotinine-associated
differentially methylated genes.
2.2. White blood cell gene comparison
White blood cells comprise different types of cells with differential
DNA methylation patterns that inﬂuence cell differentiation, including
differentiation into different blood cell types from progenitor cells [6].
The DMGs identiﬁed by Sanders et al. were compared to the list of 500
DMGs known to predict cell type in an adult population reported by
Houseman et al. [6]. The maternal dataset DMGs showed no overlap
while the fetal dataset DMGs had one overlapping DMG associated
Table 2
Numbers of differentiallymethylated genes (DMGs) identiﬁed comparing cadmium exposed versus unexposed, cotinine exposed versus unexposed, or shared cadmium/cotinine exposed
versus unexposed subjects.
Maternal dataset (n = 17 subjects) Fetal dataset (n = 17 subjects) Shared fetal, maternal dataset DMGs
Cadmiuma-associated DMGs 92 DMGs 61 DMGs 0 DMGs
Cotinineb-associated DMGs 134 DMGs 366 DMGs 12 DMGs
Shared cadmium and cotinine-associated DMGs 0 DMGs 30 DMGs
a Cadmium exposure was classiﬁed as above/below 0.20 μg/l (n = 10 exposed/n = 7 unexposed).
b Cotinine was classiﬁed as detectable/undetectable (n = 11 detectable subjects/n = 6 undetectable).
380 S. Gona et al. / Genomics Data 5 (2015) 378–380with Cd, and fourwith cotinine suggesting aminimal inﬂuence of white
blood cell composition on the DNA methylation patterns [1].
3. Validation of DNA methylation results
Validation of the DNA methylation results obtained using the MIRA
assaywas carried out at both the gene-speciﬁc and genome-wide levels.
These methods are described in detail by Sanders et al. [1] and are
summarized here. Bisulﬁte conversion, conversion of unmethylated
cytosine residues to uracil, with the Zymo EZ DNA Methylation-
Lightning kit was used for gene-speciﬁc analysis for 15 infant samples.
These changes were then quantiﬁed into appreciable methylation
values using the qPCR-based EpiTect MethyLight Assay for the PRR13
gene and compared to theMIRA results using spearman rank correlation,
which yielded signiﬁcant results. The PRR13 gene was chosen speciﬁcally
because it was one of the top ﬁve most signiﬁcant cell-death-associated
genes for infants with a fold-change in DNA methylation N1.3 and
p b 0.03.
Genome-wide analysis was done by comparing the MIRA results
from two maternal samples with results from a separate array, the
Illumina Inﬁnium HumanMethylation450 BeadChip array. The twoma-
ternal samples were selected based on stratiﬁed Cd levels and matched
with respect to maternal age, race (non-Hispanic Black), and Medicaid
coverage. For quality control, DNA methylation proportion values with
p-values b 0.0001 located within CpG islands were required. The two
samples were compared based on Cd exposed versus unexposed
status, yielding DNA methylation proportion values for each gene.
Each gene was then compared to its MIRA fold-change counterpart
using the spearman rank correlation. Among Cd-associated genes,
there was a signiﬁcant association between the Illumina Inﬁnium
HumanMethylation450 BeadChip array data and the MIRA data.
4. Conclusions
The dataset described here reﬂects DNA methylation abundances
located within CpG islands of gene promoters. There are 34 datasetsreﬂecting 17 mother–infant pairs selected for analysis based on their
levels of blood cadmiumat delivery. The present article provides further
details on the experimental design, data generation, and quality control
from the Sanders et al. study [1]. The prior study demonstrated associa-
tions between CpG island methylation and Cd levels during pregnancy
and provided evidence for the transcription factor occupancy theory of
DNA methylation patterning related to prenatal exposure to environ-
mental contaminants. Taken together, these data suggest that prenatal
exposure to toxic metals is associated with altered DNA methylation
patterning in fetal cord DNA.Acknowledgments
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